Li‐Xu Yan

机构：Guangdong Academy of Medical Sciences · ORCID：0000-0002-5584-4265

发表论文 132 篇 · 总被引 6307 次 · h-index 34

代表论文

• A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer (2025 · Cell · 被引 124)
• Multimodal radiopathological integration for prognosis and prediction of adjuvant chemotherapy benefit in resectable lung adenocarcinoma: A multicentre study (2025 · Cancer Letters · 被引 24)
• Prognostic and predictive values of a multimodal nomogram incorporating tumor and peritumor morphology with immune status in resectable lung adenocarcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 14)
• Advancing Global Health Equity in Oncology Clinical Trial Access (2024 · Cancer Discovery · 被引 11)
• Preclinical evaluation of antitumor activity and toxicity of TROP2-specific CAR-T cells for treatment of triple-negative breast cancer (2025 · Journal for ImmunoTherapy of Cancer · 被引 8)
• Partial response to lorlatinib in thoracic inflammatory myofibroblastic tumor harboring complex and rare ALK fusions: a case report (2025 · Translational Lung Cancer Research · 被引 7)